Physician profile
Sam T Hung
NPI 1750352753
$556.62
in general payments reported to CMS, 2019-2025
9 companies · $52.50 in 2025
The $52.50 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $64.07 · 2021: $120 · 2024: $32.27 · 2025: $52.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $52.50 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $52.50 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $140.30 | 2019-2024 | Ozempic |
| Pfizer INC. | $140.01 | 2019 | |
| Gilead Sciences, INC. | $101.09 | 2019-2021 | |
| Medtronic, INC. | $52.50 | 2025 | Venaseal |
| Alnylam Pharmaceuticals INC. | $42.08 | 2021 | |
| Genentech USA, INC. | $24.97 | 2020 | |
| Glaxosmithkline, LLC. | $23.39 | 2021 | |
| Abbott Laboratories | $20.37 | 2019 | |
| Endo Pharmaceuticals INC. | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Hung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.